GHK-Cu led me into a memory maze
A peptide familiar from skin care turns up in experiments on learning. The mice received GHK without copper. That small difference opens a much larger question about memory.
Aged mice and memory
The aged mice in this GHK experiment had a more interesting task than looking younger: they had to learn. At 20 months old, mice given GHK through the nose performed better in a Y-maze and a Box-maze than saline-treated controls. The paper also reported lower NFL-1, a marker of nerve-fibre damage, in both sexes, and lower MCP-1, an inflammatory marker, in female frontal cortex.
I came to GHK-Cu expecting a story about skin. My curiosity settled on a mouse learning its way around a maze. Learning seems a wonderfully concrete ambition beside the usual promises of youthful appearance.
There are substantial qualifications. This was a 2023 preprint, published before full peer review, and the experiment used the free peptide GHK. It supplies an early animal result for that form. Human neurological trials are still missing. I am interested precisely because there is something concrete to repeat: a task, a comparison group and measurements of brain injury.
Glycine, histidine, lysine
The word peptide in this site's name earns its place. GHK is a chain of three amino acids: glycine, histidine and lysine. GHK-Cu is the copper-bound form, also called Copper Tripeptide-1 on cosmetic ingredient lists. The skin-regeneration review describes the peptide in human plasma, saliva and urine, as well as its history in skin research.
Copper helps enzymes do ordinary structural work, including joining collagen and elastin. Loose copper can also take part in damaging chemistry. GHK's ability to bind the metal therefore creates several possible jobs, depending on the surroundings. In cultured nervous-system cells, free GHK protected against copper- and zinc-induced protein clumping and cell death by sequestering metal outside the cells.
That cell experiment and the mouse mazes are separate research lines. Together they tempt a tidy explanation, but the studies have yet to establish that the same mechanism produced the behavioural changes. That mechanistic connection still needs an experiment.
Skin and scalp
The more familiar GHK copper peptide story has tangible findings of its own. In human fibroblasts grown in culture, GHK-Cu increased collagen synthesis while cell number stayed unchanged. Fibroblasts are the cells that build much of the tissue's supporting material. Small topical trials collected in the 2015 review reported improvements in firmness, fine lines and wrinkle depth.
Hair brings another complication: the controlled scalp trial tested GHK combined with 5-aminolevulinic acid. Its gains in hair count are a reason to investigate that preparation. The copper peptide hair growth page goes through the actual mixture, the counts and the beef-liver question that often accompanies them.
I give these modest, specific findings more weight than the sprawling lists of things GHK-Cu supposedly rejuvenates. The skin and safety discussion includes the less flattering reports too.
Repeating the maze experiments
The other 2023 preprint used 5xFAD mice, an Alzheimer's-disease model, and reported better maze performance alongside reduced amyloid plaque burden. Both papers came from the same team. An outside laboratory repeating the tasks would give the result a firmer footing.
An experiment that measures learning and nerve injury together is worth following. So is the uncomfortable delivery question: the mouse work used the nose, skin studies used topical preparations, and a rat metabolism paper followed free GHK breaking down in blood. There is still no validated human pharmacokinetic account of GHK-Cu.
GHK-Cu has no approved drug indication. The research pages pursue the memory question; the study-amounts page examines those different routes without turning animal experiments into a human regimen.